CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-03 | Busch Matthew C. VP, Finance & CAO | Grant or award | +497 | 5,277 | ||
| 2025-03-03 | Bradway Robert A Chairman, CEO and President | Grant or award | +25,734 | 599,925 | ||
| 2025-02-21 | REESE DAVID M EVP & Chief Technology Officer | Sale | −25,225 | $304.44 | $7.7M | 36,922 |
| 2025-02-19 | Santos Esteban EVP, Operations | Option exercise | +8,711 | $156.35 | $1.4M | 80,257 |
| 2025-02-19 | Santos Esteban EVP, Operations | Sale | −8,711 | $292.84 | $2.6M | 71,546 |
| 2025-02-19 | Santos Esteban EVP, Operations | Option exercise · Nqso (Right to Buy) | −8,711 | 0 | ||
| 2025-02-19 | REESE DAVID M EVP & Chief Technology Officer | Option exercise | +8,711 | $156.35 | $1.4M | 70,858 |
| 2025-02-19 | REESE DAVID M EVP & Chief Technology Officer | Sale | −8,711 | $293.22 | $2.6M | 62,147 |
| 2025-02-19 | REESE DAVID M EVP & Chief Technology Officer | Option exercise · Nqso (Right to Buy) | −8,711 | 0 | ||
| 2025-02-19 | Miller Derek SVP, Human Resources | Option exercise | +1,524 | $156.35 | $238K | 10,068 |
| 2025-02-19 | Miller Derek SVP, Human Resources | Sale | −1,524 | $293.74 | $448K | 8,544 |
| 2025-02-19 | Miller Derek SVP, Human Resources | Option exercise · Nqso (Right to Buy) | −1,524 | 0 | ||
| 2025-02-18 | Miller Derek SVP, Human Resources | Sale | −500 | $292.56 | $146K | 8,544 |
| 2025-02-11 | Gordon Murdo EVP, Global Commercial Ops | Sale | −8,771 | $294.79 | $2.6M | 44,186 |
| 2025-02-07 | Graham Jonathan P EVP & Gen. Counsel & Secy. | Option exercise | +25,045 | $156.35 | $3.9M | 54,032 |
| 2025-02-07 | Graham Jonathan P EVP & Gen. Counsel & Secy. | Sale | −25,045 | $293.12 | $7.3M | 28,987 |
| 2025-02-07 | Graham Jonathan P EVP & Gen. Counsel & Secy. | Option exercise · Nqso (Right to Buy) | −25,045 | 0 | ||
| 2025-02-05 | Grygiel Nancy A. SVP & CCO | Sale | −1,589 | $304.47 | $484K | 7,210 |
| 2024-12-05 | Graham Jonathan P EVP & Gen. Counsel & Secy. | Gift | −6,430 | 28,903 | ||
| 2024-12-02 | Bradway Robert A Chairman, CEO and President | Gift | −96,000 | 573,855 |
Page 13 of 22 · 430 trades